Course Directors
                                     David Deitch, PhD, is the Founder of the Center for Criminality and Addiction Research, Training            

                                     and Application (CCARTA) at the currently Emeritus Professor of Clinical Psychiatry at the    

                                     University of California, San Diego. Dr. Deitch has over 45 years of experience in the development of drug                                                                        abuse treatment systems for adolescents and adults, nationally and internationally. In the non-profit public health sector, he                                      was Co-Founder of Daytop Village, Inc., and also served as Senior Vice President and Chief Clinical Officer for Phoenix House’s                                      Foundation. In the academic sector, he has had appointments at Temple University, the University of Chicago, University of                                          California at San Francisco, as well as serving as Chief of Substance Abuse Services for the University of California, San                                                  Francisco. In the government sector, he has served as Coordinator of Curriculum and Faculty for the United Nations East Central European Drug Abuse Treatment Training Project; has consulted to a variety of Department of Corrections and Ministries of Justice and Health, in Latin America, SE Asia and Europe. Dr. Deitch served during the Johnson Administration as consultant to the Presidential Commission for  the Study of Crime and Juvenile Delinquency, and the National Commission on Marijuana and Drug Abuse. During the Carter Administration, he chaired the White House Task Force on Prevention. He chaired the Curriculum Development Committee of the National Addiction Technology Transfer Centers, Technical Assistance Publication Series 21 — The Addiction Counseling Competencies: The Knowledge, Skills, and Attitudes of Professional Practice, used today as a guideline for corrections and community based substance abuse treatment organizations. He has further served as Regional Director of the Executive Committee of the Association for Medical Education and Research in Substance Abuse — Mentor Project (2000). He has numerous publications (and videos) in the field.

                                      Igor Koutsenok, MD, MS is а Professor of Psychiatry at the University of California San Diego, Director of the Center for                                               Addiction Research, Training and Application, Director of the UCSD-Second Chance Reentry Academy, and a co-director of                                           the SAMHSA South East Asia Addiction Technology Transfer Center. He graduated as a medical doctor in 1983 at the                                                     National Medical University in Kiev, (Ukraine). In 1986, he completed his psychiatry residency training and received degree as                                       psychiatrist from the Medical University in Sofia (Bulgaria). In 1992-1996 he completed fellowship in addiction psychiatry at                                         the University of London, Department of Addictive Behavior and Psychological Medicine at St. Georges Hospital Medical School. In 1996, he was recruited by the University of California San Diego, School of Medicine, Department of Psychiatry and since then he serves as faculty member of the Department. In 2013-2016 he served as Director of Prevention, Treatment, and Rehabilitation at the United Nations Office on Drugs and Crime, United Nations Office in Vienna. Over the last 20 years Dr. Koutsenok led the design and implementation of multiple training and technical assistance programs for addiction treatment, mental health practitioners, primary health care and social work practitioners, criminal justice professionals in the United States and around the world. Dr. Koutsenok served as a trainer for the National Drug Court Institute in the USA. Dr. Koutsenok is also a member of the International Motivational Interviewing Network of Trainers (MINT). For many years, Dr. Koutsenok teaches general and addiction psychiatry to medical students, psychiatry residents, psychology trainees, social workers, criminal justice professionals, and policy makers around the world. He is a recipient of numerous national and international awards. He has authored and co-authored over 50 scientific publications and 5 book chapters. Dr. Koutsenok has been invited as a presenter and trainer to hundreds of conferences and workshops in the USA and more than 40 countries around the world. He is a proud father of three.

2017 UCSD SCI Distinguished Faculty

                        Robert M. Anthenelli, M.D. is Professor and Executive Vice Chair in the Department of Psychiatry at the University of California, San                         Diego, School of Medicine where he directs the Pacific Treatment and Research Center. He previously served as the Associate Chief                           of Staff for Mental Health at the VA San Diego Healthcare System and Vice Chair for Veterans Affairs. He was formerly a Professor of                         Psychiatry, Psychology and Neuroscience at the University of Cincinnati, College of Medicine where he founded and directed the        

                        Center for Treatment, Research & Education in Addictive Disorders and the Addiction Sciences Division.

Dr. Anthenelli earned his baccalaureate degree from The Johns Hopkins University in Baltimore, Maryland, USA and his MD degree from The Johns Hopkins University School of Medicine. After graduating medical school, he completed his internship in internal medicine at Mercy Hospital in Baltimore. Dr. Anthenelli did residency training in psychiatry at the University of California, San Diego, School of Medicine. Additional post-doctoral training included a 2-year fellowship in addiction psychiatry research that was funded by the Department of Veterans Affairs.

The overarching theme of Dr. Anthenelli’s research is to develop improved treatments for tobacco and alcohol dependence by better understanding the neurobiology of these disorders. His lab group is also interested in the genetic influences on these disorders, the relationship between stress and relapse to addiction, and sex differences in stress and treatment responsivity. Funding for his research is provided by the National Institute on Alcohol Abuse and Alcoholism, the National Institute on Drug Abuse, the Department of Veterans Affairs, and various industry sponsors.  

                               Anna Blyum, MS is originally from Kazakhstan. She is an alumna of E. Muskie Graduate Fellowship and holds BAs in Foreign                                         Languages and Physical Training and MS in Urban Policy Analysis and Management from The New School, NYC.

                                Presently, she serves as a Senior Program Officer for Central Asia and Afghanistan at the Colombo Plan ICCE in support of the Center’s mission to professionalize the drug demand reduction workforce globally. Ms. Blyum is a credentialed International Certified Addiction Professional (ICAP I) and continues her extensive training in the field.

Her research interest lies in the interface between substance use and delinquency in youth and adolescents, or, more specifically, on the evaluation of prevention and treatment policies and interventions related to this population. 

                          Thom Browne, Jr. Rubicon Global Enterprises: President and CEO (Aug. 2015 – present) Colombo Plan Secretariat: Chief Executive                             Officer (Jan. 2016 – present) Provides global technical assistance on drug prevention, treatment, recovery, and criminal justice                                      issues. Chairs international working groups to develop certification for addictions counselors, licensing for treatment centers, and                              networks of treatment/prevention professionals. Serves as expert advisor to selected international organizations on counter-                                      narcotics issues. Develops specialized programs addressing unique international challenges such as identification of toxic               adulterants added to drugs of abuse and related public health responses. Developed the U.S. government's program and approach                         to international drug demand reduction for over 25 years as the U.S. Department of State's Division Director for Criminal Justice                               Programs.

                              Patricia A. Judd, Ph.D. is a Clinical Professor of the Psychiatry at the UCSD School of Medicine, Department of Psychiatry.  She is                               Director of the UCSD Outpatient Psychiatric Services, Hillcrest. She received her PhD in Clinical Psychology from the California                                     School of Professional Psychology, San Diego, and her Masters in Social Work from San Diego State University. 

                               Phaedon Kaloterakis, PhD is the Assistant Director of KETHEA, KETHEA being one of the largest drug treatment organizations                                     in Europe.

                                Phaedon has been involved with the addiction field since 1980 and is a much sought after speaker worldwide in international                                     conferences on addiction and has published many articles and scientific papers.

                                He lectures at various universities in Greece and abroad including the National School of Judges and the National Police                                               Academy.

Phaedon also serves at various international boards such as, among others, the International Certification and Reciprocity Consortium (ICRC), the World Federation of Therapeutic Communities (WFTC), the European Federation of Therapeutic Communities (EFTC) and the Therapeutic Communities Journal’s International Editorial Advisory Group.

Phaedon represents KETHEA at the Economic and Social Council (ECOSOC) at the U.N. and is a scientific consultant of the United Nations Office on Drugs and Crime (UNODC).

                              David Grelotti, MD is an Assistant Professor of Psychiatry at the University of California San Diego and an Investigator at the                                         University of California Center for Medicinal Cannabis Research. He graduated from medical school at The Johns Hopkins                                             University School of Medicine and completed residency training in the Harvard Medical School Combined Pediatrics, Adult                                           Psychiatry, and Child Psychiatry Residency Training Program at Massachusetts General Hospital and McLean Hospital. After                                         residency training, he worked extensively in Haiti and Africa to close the treatment gap for mental, neurological, and substance                                   use disorders. At UC San Diego, he is the Director of HIV Psychiatry and conducts research on HIV syndemics, global mental                                         health, and medicinal cannabis. Active research efforts include: novel systems for the delivery of mental health treatment for people living with HIV in Haiti and the US; the relationship between HIV and cannabis, heroin, and recreational antiretroviral use in South Africa; and cannabis-related driving impairment and a randomized, placebo-controlled clinical trial of cannabis for low back pain at the Center for Medicinal Cannabis Research. His research is funded by the National Institutes of Health and the State of California.

                              Secretary Scott Kernan served as CDCR Undersecretary for Operations from March to December 2015. He was owner at                                           Kernan Consulting from 2011 to 2015. He served as Undersecretary for Operations at CDCR from 2008 to 2011. He was Chief                                       Deputy Secretary of Adult Operations from 2007 to 2008 and Deputy Director of Adult Institutions from 2006 to 2007.

                              He served as Warden at California State Prison, Sacramento, from 2004 to 2006 and Warden at Mule Creek State Prison from                                       2003 to 2004, where he also served as a Chief Deputy Warden from 2001 to 2003 and as a Correctional Administrator from                                         2000 to 2001.
He served as a Correctional Captain from 1991 to 2000, as a Correctional Lieutenant from 1987 to 1991, an Associate Budget Analyst from 1986 to 1987, a Correctional Sergeant from 1985 to 1986 and a Correctional Officer from 1983 to 1985. He served in the U.S. Navy from 1979 to 1982.

                                          Carla Marienfeld, MD, is an addiction psychiatrist and an Associate Clinical Professor of Psychiatry at University of                                                       California San Diego.  Clinically, she focuses on the treatment of patients with substance use disorders and co-morbid                                                   psychiatric conditions.  She previously worked at a large outpatient addiction treatment program serving over 5000                                                       patients.  Her academic interests focus on implementation research and large-data health outcomes for patients with                                                   substance use disorders, as well as training and education in Motivational Interviewing.  She attended Baylor College of                                                 Medicine in Houston, TX, where she completed the International Health Track, served nationally on the Board of Trustees                                             of the American Medical Student Association (AMSA), and earned Alpha Omega Alpha (AOA) Medical Honors Society and Honors distinction.  During psychiatry residency at Yale, she served as chief resident, a National Institute of Drug Abuse R25 Research Fellow, and as the resident representative to the Accreditation Council for Graduate Medical Education (ACGME), while also earning several awards and fellowships.  She completed a fellowship in Addiction Psychiatry at Yale.  During residency and her early faculty years, she founded and led the Yale Global Mental Health Program.  She served as the site training director for the Yale New Haven Hospital Addiction Psychiatry Fellowship and supervised and taught medical students for psychiatry, residents for global mental health, and fellows for addiction psychiatry.  She has come to UCSD to help in the development and implementation of a new Addiction Recovery and Treatment Program.  This will be a full service ambulatory program for the treatment of substance use and other co-occurring mental disorders (i.e. anxiety, depression, PTSD), offering a continuum of services including a comprehensive evaluation, individual, family and group therapy, medication management, and linkage to community resources.  She is the Director for Addiction Services and the Medical Director of the Addiction Recovery and Treatment Program at UCSD.

                                Bill McGlynn is a Senior Advisor to the Bureau of International Bureau of International Narcotics and Law                                                                         Enforcement Affairs (INL).  He has helped develop and implement international drug treatment and prevention programs in                                         Africa, Asia, and Latin America. 

                                Bill served as Deputy U.S. Permanent Representative to the Organization of American States (OAS).  From 2008 to 2011, he was                                    Principal Deputy Assistant Secretary of INL. 

His other work with the Department of State includes as Director of the Political Advisor Program in the Bureau of Political-Military Affairs, Deputy Chief of Mission at the U.S. Embassy in Portugal (2001-2004), and advisor on foreign assistance to Deputy Secretary Lawrence Eagleburger.  He served in the U.S. Embassies to Haiti, Gabon, the European Union, and Austria.  

                                        Mark B. Reed, PhD is the Interim Associate Dean in the College of Health and Human Services and a Professor in the San                                            Diego State University (SDSU) School of Social Work. He is a founding faculty member in the SDSU/UCSD Interdisciplinary                                              Research on Substance Use doctoral program. Dr. Reed’s research focuses on alcohol and other drug use etiology and                                                  prevention with an emphasis on social ecological models of substance use behaviors as well as Screening, Brief                                                              Intervention, Referral to Treatment (SBIRT) approaches to alcohol misuse. He is well published in top substance use/public                                          health journals and has served as Principal Investigator, Co-Principal Investigator, or Co-Investigator on grants and                                                        contracts funded by the National Institutes of Health (NIAAA), the Congressionally Directed Medical Research Program,                                                  California Tobacco-Related Disease Research Program, the Flight Attendants Medical Research Institute, and The Ohio State University. He is the incoming President of the American Academy of Health Behavior and is an ad-hoc reviewer for over 20 substance use/public health journals and serves as the Co-Editor-in-Chief for the International Journal of Alcohol and Drug Research. In his spare time Dr. Reed can be found mountain biking or road cycling in San Diego county and beyond. 

                                        Marc A. Schuckit, MD, is Professor of Psychiatry and Director of the Alcohol and Drug Treatment Program, University of                                               California, San Diego and the VA San Diego Healthcare System.  Dr. Schuckit received his BS from the University of                                                         Wisconsin, an MD from Washington University, interned at Cedars Sinai Medical Center, and was a resident in psychiatry at                                         Washington University and UCSD. He was a special advisor to the Commanding Officer of the Naval Health Research                                                     Center, and the first Director of the Alcohol and Drug Institute, University of Washington (1975-1978). He returned to San                                             Diego as Professor and Director of the Alcohol and Drug Treatment Program, University of California, San Diego and the VA                                         San Diego Healthcare System. Dr. Schuckit’s major focus is alcohol and drugs. He was Chair of the DSM-IV substance                                                     disorders workgroup and has published papers about the optimal diagnostic criteria for substance use disorders.                   Regarding the genetics of alcoholism, he has carried out adoption studies, identified a genetic characteristic that impacts on elevated alcoholism risk (the low level of response to alcohol), and is now searching for related genes. He is currently completing a 20-year follow-up (97% success rate) of sons of alcoholics where he is trying to identify environmental events that might relate to whether biological predisposition toward alcohol dependence is expressed. An additional research area is co-morbidity between substance use disorders and major psychiatric conditions.

Dr. Schuckit directs the Alcohol and Drug Treatment Program at the VA San Diego Healthcare System, supervising residents, medical students and staff. He is also a major contact person regarding alcohol and drug problems in faculty and staff at UCSD and the San Diego VA. Additional clinical interests include the treatment of depressive disorders, anxiety conditions, and geriatric psychiatric populations.

                                      Joseph Skrajewski, MA, MFTI, is executive director of Medical and Professional Education at the Hazelden Betty Ford                                                   Foundation. He leads the Summer Institute for Medical Students (SIMS), Professionals in Residence (PIR) program, Addiction                                       Medicine Fellowship, and Course on Addiction and Recovery Education (CARE), while also overseeing program design,                                                   development and medical education partnerships. Joseph serves on the board of the Desert Chapter of the California                                                    Association of Marriage and Family Therapists and as an Adjunct Clinical Instructor of Family Medicine at the University of                                            Southern California's Keck School of Medicine. He has presented all over the world on numerous topics related to addiction,                                        and is a person in long-term recovery himself. Before entering the fields of psychology and healthcare, Joseph worked on                                            Wall Street.

                                 María Luisa Zúñiga, PhD is Professor in the School of Social Work at San Diego State University (SDSU) and Associate                                                  Adjunct Professor in the Division of Global Public Health and Department of Pediatrics, UC San Diego (UCSD). Serves as the                                          Campus Director of the SDSU-UCSD Joint Doctoral Program in Interdisciplinary Research on Substance Use (JDP)                                                              ( The JDP is a new doctoral program designed to train the next generation of substance use                                      researchers to lead high caliber, high impact and meaningful substance use research to reduce the impact of problems related                                  to substance use, misuse, addiction and co-occurring conditions.

She is an epidemiologist with over 18 years of experience conducting transnational and Community-Based Participatory Research. Dr. Zúñiga’s research goal is to improve health among persons of Latin American origin who are at risk for or adversely impacted by alcohol and drug use, poor mental health, and TB/HIV.  She has worked extensively with immigrant communities and communities in the U.S.-Mexico border region as well as Mexican transnational and domestic migrants and their families in Mexico. Her ongoing research is designed to understand and improve engagement and retention of patients in health care, patient-clinician communication, and binational care continuity in the context of the U.S.-Mexico border region. Specific populations with whom she works include persons living with HIV and/or Tuberculosis, and persons impacted by substance abuse. Recent efforts include development of interdisciplinary collaborations in HIV/TB/Substance use research with colleagues in the U.S. and Brazil.

Summer clinical institute in addiction studies